Rodin Therapeutics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $950M

  • Investors
  • 1

Rodin Therapeutics General Information

Description

Developer of epigenetic drugs intended to be used for the treatment of cognitive disorders and diseases of the brain. The company's epigenetic drugs are harnessing the power of epigenetic regulation of neuronal function by HDAC complex modulation, enabling patients to restore synaptic function, health and survival in degenerative brain diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 300 Technology Square
  • 8th Floor
  • Cambridge, MA 02139
  • United States
+1 (857)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 300 Technology Square
  • 8th Floor
  • Cambridge, MA 02139
  • United States
+1 (857)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rodin Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 25-Nov-2019 $950M Completed Product Development
5. Grant 13-Nov-2017 Completed Product Development
4. Later Stage VC (Series C) 18-Sep-2017 Completed Product Development
3. Early Stage VC (Series B) 06-Jan-2016 Completed Startup
2. Early Stage VC (Series A) 29-May-2014 $12.9M $12.9M Completed Startup
1. Seed Round 27-Jun-2013 Completed Startup
To view Rodin Therapeutics’s complete valuation and funding history, request access »

Rodin Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A3
Series A2 1,649,147 $0.000100 5% $1.1 $1.1 1x $1.1 4.13%
Series A1 1,612,675 $0.000100 5% $1 $1 1x $1 4.04%
To view Rodin Therapeutics’s complete cap table history, request access »

Rodin Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of epigenetic drugs intended to be used for the treatment of cognitive disorders and diseases of the brain. Th
Drug Discovery
Cambridge, MA

Boston, MA
 

Needham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rodin Therapeutics Competitors (81)

One of Rodin Therapeutics’s 81 competitors is CervoMed, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CervoMed Formerly VC-backed Boston, MA
Mighty Therapeutics Private Equity-Backed Needham, MA
Aquinnah Venture Capital-Backed Cambridge, MA
NeuroNascent Venture Capital-Backed Clarksville, MD
Cognition Therapeutics Formerly VC-backed New York, NY
You’re viewing 5 of 81 competitors. Get the full list »

Rodin Therapeutics Patents

Rodin Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2020014602-A1 Bicyclic inhibitors of histone deacetylase Inactive 13-Jul-2018
WO-2020014605-A1 Inhibitors of histone deacetylase Inactive 13-Jul-2018
AU-2018313094-A1 Bicyclic inhibitors of histone deacetylase Inactive 07-Aug-2017
WO-2019032528-A1 Bicyclic inhibitors of histone deacetylase Inactive 07-Aug-2017
WO-2019032528-A8 Bicyclic inhibitors of histone deacetylase Inactive 07-Aug-2017 A61K31/437
To view Rodin Therapeutics’s complete patent history, request access »

Rodin Therapeutics Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alzheimers Drug Discovery Foundation Not-For-Profit Venture Capital Minority
Atlas Venture Venture Capital Minority
Biogen Corporation Minority
GV Corporate Venture Capital Minority
Hatteras Venture Partners Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Rodin Therapeutics FAQs

  • When was Rodin Therapeutics founded?

    Rodin Therapeutics was founded in 2013.

  • Where is Rodin Therapeutics headquartered?

    Rodin Therapeutics is headquartered in Cambridge, MA.

  • What industry is Rodin Therapeutics in?

    Rodin Therapeutics’s primary industry is Drug Discovery.

  • Is Rodin Therapeutics a private or public company?

    Rodin Therapeutics is a Private company.

  • What is the current valuation of Rodin Therapeutics?

    The current valuation of Rodin Therapeutics is .

  • What is Rodin Therapeutics’s current revenue?

    The current revenue for Rodin Therapeutics is .

  • How much funding has Rodin Therapeutics raised over time?

    Rodin Therapeutics has raised $57.2M.

  • Who are Rodin Therapeutics’s investors?

    Alzheimers Drug Discovery Foundation, Atlas Venture, Biogen, GV, and Hatteras Venture Partners are 5 of 11 investors who have invested in Rodin Therapeutics.

  • Who are Rodin Therapeutics’s competitors?

    CervoMed, Mighty Therapeutics, Aquinnah, NeuroNascent, and Cognition Therapeutics are some of the 81 competitors of Rodin Therapeutics.

  • When was Rodin Therapeutics acquired?

    Rodin Therapeutics was acquired on 25-Nov-2019.

  • Who acquired Rodin Therapeutics?

    Rodin Therapeutics was acquired by Alkermes.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process